Infosys (INFY) shares dropped 5.5% after the company reported flat fiscal Q2 earnings late Thursday, missing analysts' expectations.
More than 32.1 million shares traded intraday, compared with a daily average of about 19.5 million.
Aardvark Therapeutics (AARD) shares slumped 60% amid heavy trading after the company released on Friday exploratory efficacy data from its previously terminated phase 3 HERO and open-label extension trials.
Over 13.5 million shares traded intraday versus a daily average of roughly 146,000.
Bloom Energy's (BE) shares face near-term pressure as higher working capital requirements ate into its Q3 cash flow, according to an Oppenheimer note Friday.
The stock retreated 11.3% as intraday trading volume jumped to over 28 million from a daily average of about 15.8 million.
Price: 12.49, Change: -0.73, Percent Change: -5.52
Comments